Table 3.

Representation of the values for risk of metastasis.

Phase	Gene	Adjusted p Value (*)	Adjusted p Value (cn)	Ct Mean No Metastasis ± SD	Ct Mean Metastasis ± SD	Copies Per µL Mean No Metastasis ± SD	Copies Per µL Mean Metastasis ± SD
B	HV1-short	0.020	0.069	24.54 ± 4.18	22.06 ± 2.08	2.38 ± 3.77	2.55 ± 2.04
	HV1-long	0.035	0.133	23.92 ± 4.61	21.35 ± 2.56	2.67 ± 3.92	2.56 ± 1.72
	CYB-short	0.078	0.223	25.71 ± 4.29	23.69 ± 2.54	2.08 ± 3.11	1.90 ± 1.35
	HBB-long	0.020	0.029	33.52 ± 2.99	36.09 ± 2.69	1.07 ± 2.02	0.09 ± 0.16
C	CYB-short	0.359	0.037	19.95 ± 2.73	20.67 ± 2.03	24.36 ± 29.66	10.18 ± 7.37
	HBB-short	0.001	0.002	19.18 ± 2.41	21.24 ± 0.89	1092.33 ± 1254.73	194.36 ± 102.38
	HBB-long	0.006	0.012	30.37 ± 3.71	32.99 ± 1.55	23.39 ± 49.39	0.38 ± 0.48
D	HBB-long	0.001	0.001	31.84 ± 3.48	36.03 ± 2.77	7.39 ± 15.66	0.07 ± 0.09
F	HBB-long	0.007	0.014	31.72 ± 2.13	33.44 ± 1.34	2.22 ± 4.42	0.22 ± 0.19

Ct: cycle threshold; CYB: Apocytochrome B; HBB: Hemoglobin subunit beta; HV1: Hypervariable region 1; SD: Standard deviation. HBB as nuclear marker vs. HV1 and CYB as mitochondrial markers. (*) Just FDR adjusted p values comparing genes in cases vs. controls by qPCR analysis. Adjusted p values (cn) represent values of comparisons cases vs. controls in copy number by dPCR analysis. The italics indicates significant p values.